(Q58197214)

1

0 references

Narayanan Surendran

2

0 references

Elizabeth A. Lunney

3

0 references

Mark S. Plummer

4

0 references

Kimberly S. Para

5

0 references

Aurash Shahripour

6

0 references

James H. Fergus

7

0 references

James S. Marks

8

0 references

Roman Herrera

9

0 references

Susan E. Hubbell

10

0 references

Christine Humblet

11

0 references

Barbra H. Stewart

13

0 references

Tomi K. Sawyer

Bioorganic & Medicinal Chemistry Letters

14

0 references

language of work or name

English

0 references

publication date

July 1997

0 references

published in

0 references

volume

7

0 references

issue

14

0 references

page(s)

1909-1914

0 references

cites work

New intracellular targets for therapeutic drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Targeting signal transduction for disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Oncogenes, Protein Tyrosine Kinases, and Signal Transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Tyrosine kinase inhibition: an approach to drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Phosphotyrosine phosphatases with SH2 domains: regulators of signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

SH2 domain protein interaction and possibilities for pharmacological intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

SH2 and SH3 domains: potential targets for anti-cancer drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

SH2 and SH3-containing adaptor proteins: redundant or independent mediators of intracellular signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Evidence that c-src is involved in the process of osteoclastic bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Novel phosphotyrosine mimetics in the design of peptide ligands for pp60src SH2 domain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Design of peptidomimetic ligands for the pp60src SH2 domain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Potent Inhibition of Insulin Receptor Dephosphorylation by a Hexamer Peptide Containing the Phosphotyrosyl Mimetic F2Pmp

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

F2(Pmp)2-TAM zeta 3, a novel competitive inhibitor of the binding of ZAP-70 to the T cell antigen receptor, blocks early T cell signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Minireview: nucleotide prodrugs

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

New N alpha-guanidinobenzoyl derivatives of hirudin-54-65 containing stabilized carboxyl or phosphoryl groups on the side chain of phenylalanine-63

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Development and validation of an ion-pair reversed-phase high-performance liquid chromatographic method for the separation of phosphonodipeptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

Synthesis and antitumor evaluation of bis[(pivaloyloxy)methyl] 2'-deoxy-5-fluorouridine 5'-monophosphate (FdUMP): a strategy to introduce nucleotides into cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021

IAM chromatography: an in vitro screen for predicting drug membrane permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2897%2900334-X

7 January 2021